FDA Guidance
Official FDA guidance documents for medical devices and radiation-emitting products
106 resourcesFDA and Industry Actions on 510(k) Submissions: Effect on FDA Review Clock and Goals
Final FDA guidance on 510(k). Published 2017 by CDRH/CBER.
View DocumentUser Fees for 513(g) Requests for Information
Final FDA guidance on user fees. Published 2017 by CDRH/CBER.
View DocumentDeciding When to Submit a 510(k) for a Software Change to an Existing Device
Final FDA guidance on software & digital health. Published 2017 by CDRH/CBER.
View DocumentTechnical Considerations for Additive Manufactured Medical Devices
Final FDA guidance on manufacturing. Published 2017 by CDRH/CBER.
View DocumentUnique Device Identification: Direct Marking of Devices
Final FDA guidance on udi. Published 2017 by CDRH/CBER.
View DocumentUse of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based IVDs
Final FDA guidance on ivd & diagnostics. Published 2018 by CDRH/CBER.
View DocumentAcceptance of Clinical Data to Support Medical Device Applications and Submissions: FAQ
Final FDA guidance on clinical evidence. Published 2018 by CDRH/CBER.
View DocumentFDA Categorization of IDE Devices to Assist CMS with Coverage Decisions
Final FDA guidance on ide. Published 2017 by CDRH/CBER.
View DocumentMedical Device Accessories — Describing Accessories and Classification Pathways
Final FDA guidance on classification. Published 2017 by CDRH/CBER.
View DocumentAppropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices
Final FDA guidance on standards & conformity. Published 2018 by CDRH/CBER.
View DocumentUse of Electronic Health Record Data in Clinical Investigations
Final FDA guidance on clinical evidence. Published 2018 by CDRH/CBER.
View DocumentLogical Observation Identifiers Names and Codes for In Vitro Diagnostic Tests
Final FDA guidance on ivd & diagnostics. Published 2018 by CDRH/CBER.
View DocumentUser Fees and Refunds for Premarket Approval Applications and Device BLAs
Final FDA guidance on user fees. Published 2018 by CDRH/CBER.
View DocumentManufacturing Site Change Supplements: Content and Submission
Final FDA guidance on manufacturing. Published 2018 by CDRH/CBER.
View DocumentBenefit-Risk Factors to Consider When Determining Substantial Equivalence in 510(k) Submissions
Final FDA guidance on 510(k). Published 2018 by CDRH/CBER.
View DocumentFactors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo
Final FDA guidance on benefit-risk. Published 2019 by CDRH/CBER.
View DocumentUnique Device Identification: Convenience Kits
Final FDA guidance on udi. Published 2019 by CDRH/CBER.
View DocumentThe Least Burdensome Provisions: Concept and Principles
Final FDA guidance on submission process. Published 2019 by CDRH/CBER.
View DocumentHumanitarian Device Exemption (HDE) Program
Final FDA guidance on hde. Published 2019 by CDRH/CBER.
View DocumentRefuse to Accept Policy for 510(k)s
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
View DocumentThe Abbreviated 510(k) Program
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
View DocumentThe Special 510(k) Program
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
View DocumentAnnual Reports for Approved Premarket Approval Applications (PMA)
Final FDA guidance on pma. Published 2019 by CDRH/CBER.
View DocumentSafety and Performance Based Pathway
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
View Document